@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:11766; a Protein: . sub:_2 geneProductOf: hgnc:6156; a Protein: . sub:_3 rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:_4 occursIn: obo:CLO_0003734, species:9606; rdf:object sub:_3; rdf:predicate belv:decreases; rdf:subject schem:SB%20202129; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"SB 202129\") -| (p(HGNC:TGFB1) -> p(HGNC:ITGB3))", "p(HGNC:TGFB1) -> p(HGNC:ITGB3)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_6; pav:version "20131211" . sub:_5 prov:value "However, the p38 MAPK inhibitor SB203580 (10 M), and the more potent inhibitor SB202129 at a concentration of 0.2 M and higher, decreased 3 subunit and v3 integrin expression induced by TGF1 (Fig. 7, A and B)."; prov:wasQuotedFrom pubmed:18353785 . sub:_6 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:18353785; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:18.673+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }